Prevalence of Abdominal Aortic Aneurysm in Patients with Coronary Artery Stenosis Undergoing Angiography from 2011 to 2016

Abstract

An abdominal aortic aneurysm (AAA) is an abnormal local dilation of the aorta. The relationship between coronary artery disease (CAD) and the AAA is well established. This study evaluated the prevalence of AAAs in patients with CAD who underwent angiography in a hospital. Between 2011 and 2016, a total of 576 patients with coronary artery stenosis and a stenosis level greater than 50% in at least one of their coronary arteries were referred for angiography. Patient data were collected from medical records, and a checklist was created to document demographic information, underlying medical conditions, and ultrasound findings. Data were analyzed using either the chi-square or Fisher's exact test, depending on the specific variables being examined. The prevalence of AAAs among 576 patients with CAD was 6.3%. The difference in the distribution of AAAs in patients based on smoking (p = 0.003) and high blood pressure history (p < 0.001) was statistically significant. AAAs in patients with CAD showed no significant difference in hyperlipidemia (p = 0.13) and diabetes (p = 0.06). The prevalence of AAA was not associated with an increase in the number of involved vessels (p = 0.06). The prevalence of AAAs in patients with CAD angiography was found to be 6.3%. The prevalence increased significantly with age, and females had a higher prevalence than males. The prevalence increased with the increased number of involved vessels but not significantly. The study highlights the importance of prevention and early detection to avoid rupture and high mortality rates.

Keywords

prevalence - abdominal aortic aneurysm - CAD - angiography

Contributors' Statement

SA.M.B. performed patient coronary angiography. S.B. performed the ultrasonography under the direct supervision of G.A. G.A. was the corresponding author and the head of the article submission. G.S. performed the first part of data analysis and data recording. A.Z. did the final clinical analysis and article composition. The study's final approval and review procedure was done under the contribution of all authors. All authors read and approved the final article.

Publikationsverlauf

Eingereicht: 22. Juli 2025

Angenommen: 12. August 2025

Artikel online veröffentlicht:
03. September 2025

• References

• 1 Golledge J. Abdominal aortic aneurysm: update on pathogenesis and medical treatments. Nat Rev Cardiol 2019; 16 (04) 225-242
• 2 Tong J, Cohnert T, Regitnig P, Holzapfel GA. Effects of age on the elastic properties of the intraluminal thrombus and the thrombus-covered wall in abdominal aortic aneurysms: biaxial extension behaviour and material modelling. Eur J Vasc Endovasc Surg 2011; 42 (02) 207-219
• 3 Durieux R, Van Damme H, Labropoulos N. et al. High prevalence of abdominal aortic aneurysm in patients with three-vessel coronary artery disease. Eur J Vasc Endovasc Surg 2014; 47 (03) 273-278
• 4 Mirsharifi R, Zhand N, Shahriyarian S, Meysamie A, Mirsharifi A, Aminian A. The prevalence of abdominal aortic aneurysm in Iranian male population over 65 years old. Tehran Univ Med J 2011;69(5)
• 5 Osmani F, Azarkar G. Fitting logistic regression models to assess vitamin D deficiency with clinical parameters in chronic hepatitis B patients. Infect Dis Model 2021; 6: 612-617
• 6 Osmani F, Hajizadeh E, Rasekhi AA. Joint frailty modeling for multiple recurrent events and its application in patients with breast cancer. J Obstet Gynecol Cancer Res 2022; 3 (02) 53-58
• 7 Vos CG, de Vries JP, Werson DA, van Dongen EP, Schreve MA, Ünlü Ç. Evaluation of five different aneurysm scoring systems to predict mortality in ruptured abdominal aortic aneurysm patients. J Vasc Surg 2016; 64 (06) 1609-1616
• 8 Kapila V, Jetty P, Wooster D, Vucemilo V, Dubois L. Canadian Society for Vascular Surgery. Screening for abdominal aortic aneurysms in Canada: 2020 review and position statement of the Canadian Society for Vascular Surgery. Can J Surg 2021; 64 (05) E461-E466
• 9 Mansouri P, Hajizadeh E, Osmani F. Analysis of risk factors for psoriasis recurrence using proportional rates model. J Skin Stem Cell 2014;1(3)
• 10 Osmani M, Osmani F, Pourhoseingholi MA. Comparison of decision tree and logistic regression for prediction of functional dyspepsia and gastroesophageal reflux disease in Tehran province using Rome III. Modern Care J 2019; 16 (04) e94669
• 11 Gennai S, Andreoli F, Saitta G. et al. Two decades of abdominal aortic endovascular repair with the anatomical fixation at the aortic bifurcation in a large single-center experience. J Endovasc Ther 2022; 29 (01) 42-56
• 12 Prinssen M, Verhoeven EL, Buth J. et al; Dutch Randomized Endovascular Aneurysm Management (DREAM)Trial Group. A randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms. N Engl J Med 2004; 351 (16) 1607-1618
• 13 Van Kuijk JP, Flu WJ, Dunckelgrun M, Bax JJ, Poldermans D. Coronary artery disease in patients with abdominal aortic aneurysm: a review article. J Cardiovasc Surg (Torino) 2009; 50 (01) 93-107
• 14 Dehghan R, Shakeri A, Nemati M, Ghaffari S, Neshat M. Prevalence of Abdominal Aortic Aneurysm in Patients with Coronary Artery Disease. Med J Tabriz Uni Med Sci Health Services 2010; 32 (03) 35-39
• 15 Bergersen L, Kiernan MS, McFarlane G, Case TD, Ricci MA. Prevalence of abdominal aortic aneurysms in patients undergoing coronary artery bypass. Ann Vasc Surg 1998; 12 (02) 101-105
• 16 Fink HA, Lederle FA, Roth CS, Bowles CA, Nelson DB, Haas MA. The accuracy of physical examination to detect abdominal aortic aneurysm. Arch Intern Med 2000; 160 (06) 833-836
• 17 Lederle FA, Kane RL, MacDonald R, Wilt TJ. Systematic review: repair of unruptured abdominal aortic aneurysm. Ann Intern Med 2007; 146 (10) 735-741
• 18 Fleming C, Whitlock EP, Beil TL, Lederle FA. Screening for abdominal aortic aneurysm: a best-evidence systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2005; 142 (03) 203-211
• 19 Cornuz J, Sidoti Pinto C, Tevaearai H, Egger M. Risk factors for asymptomatic abdominal aortic aneurysm: systematic review and meta-analysis of population-based screening studies. Eur J Public Health 2004; 14 (04) 343-349
• 20 Lovell MB, Harris KA, Derose G, Forbes TL, Fortier M, Scott B. A screening program to identify risk factors for abdominal aortic aneurysms. Can J Surg 2006; 49 (02) 113-116
• 21 Madaric J, Vulev I, Bartunek J. et al. Frequency of abdominal aortic aneurysm in patients > 60 years of age with coronary artery disease. Am J Cardiol 2005; 96 (09) 1214-1216
• 22 Hanly AM, Javad S, Anderson LP, Horgan J, Kelly CJ. Screening for abdominal aortic aneurysms in cardiovascular patients. J Surg Res 2006; 132 (01) 52-55
• 23 Mohammadifard M, Mamashli A, Kazemi T. Prevalence and risk factors for abdominal aortic aneurysm in people over 65 years old who referred to the ultrasound centers of educational hospitals in Birjand in 2014. DOAJ 2015; 22 (03) 248-255
• 24 Derubertis BG, Trocciola SM, Ryer EJ. et al. Abdominal aortic aneurysm in women: prevalence, risk factors, and implications for screening. J Vasc Surg 2007; 46 (04) 630-635
• 25 Vardulaki KA, Prevost TC, Walker NM. et al. Incidence among men of asymptomatic abdominal aortic aneurysms: estimates from 500 screen detected cases. J Med Screen 1999; 6 (01) 50-54
• 26 Osmani F, Ziaee M. Assessment of the risk factors for vitamin D3 deficiency in chronic hepatitis B patient using the decision tree learning algorithm in Birjand. Inform Med Unlocked 2021; 23: 100519
• 27 Singh K, Bønaa KH, Jacobsen BK, Bjørk L, Solberg S. Prevalence of and risk factors for abdominal aortic aneurysms in a population-based study: the Tromsø study. Am J Epidemiol 2001; 154 (03) 236-244
• 28 Osmani F, Hajizadeh E, Mansoori P. Use of smoothing methods for estimating the coefficients of time dependent rate models in survival analysis and its application in psoriasis disease. Majallah-i Ipidimiyuluzhi-i Iran 2016; 12 (03) 36-46
• 29 Owens DK, Davidson KW, Krist AH. et al; US Preventive Services Task Force. Screening for abdominal aortic aneurysm: US Preventive Services Task Force recommendation statement. JAMA 2019; 322 (22) 2211-2218